Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

<p>Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.<br /> <br /> <strong>Related Content:</strong></p> <ul> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.3803?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction</a></li> <li><a class="related-article" href= "https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.3846?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links" target="_blank" rel="noopener">Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive</a></li> </ul>